Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Brain gliomas progress as function of crucial gene is lost

07.04.2003


For the first time, researchers are characterizing the molecular processes that turn brain cancer deadly, and their work may result in a diagnostic test that can predict patient survival.



The research, by scientists at The University of Texas M. D. Anderson Cancer Center demonstrates that degree of loss of a crucial tumor suppressor gene, the AP-2( transcription factor, correlates with progression of different human gliomas.

For example, researchers found that normal brain tissue, as well as grade II gliomas, maintained expression of AP-2(, whereas 96 percent of grade III glioma, and almost 99 percent of grade IV glioma had lost AP-2(.


"Although previous molecular markers have been identified in malignant gliomas, none have exhibited such a strong correlation with progression, indicating the pivotal role of this gene," says Amy Heimberger, M.D., assistant professor in the Department of Neurosurgery.

The findings one day may be clinically important, says Eric McGary, M.D., Ph.D., a clinical fellow.

If validated through further study, the results can help scientists devise a diagnostic test to check for loss of function of the AP-2( gene, which can help doctors and patients know about treatment options. "No such test exists like that now," he says. Dr. Heimberger is following the long-term survival of patients within the various grades of gliomas to determine if loss of the AP-2( confers a more serious prognosis.

McGary led the effort to characterize how cancer develops when the AP-2( gene, which normally protects against cancer development, is lost. They have found that other tumors such as melanoma become increasingly deadly when the gene is no longer active, and have described its role in breast and prostate cancer as well.

The AP-2( transcription factor controls the expression of many genes, including c-Kit, which regulates cellular proliferation and differentiation, MUC18, an adhesion molecule involved in angiogenesis, and MMP2, which is involved in invasion. When AP-2( is lost, less c-Kit, but more MUC18 and MMP2 are produced, resulting in an increased potential of the cell to grow and divide uncontrollably.

"As such, AP-2( acts as a tumor suppressor gene," says Menashe Bar-Eli, PhD, professor in the Division of Cancer Medicine and a senior member of the research team.

Looking at tumor samples taken from 279 patients with different kinds of brain cancer, the research team used a tissue array constructed by Dr. Gregory Fuller, associate professor in the Department of Pathology, to look for AP-2( gene expression.

In addition to their findings of different stages of gliomas, they found that 21.5 percent of oligodendrogliomas did not express AP-2(, but this increased to 66 percent in cases of anaplastic oligodendrogliomas.

The team also looked at glioblastomas, which are the most common malignant brain tumors in adults and are the most resistant and deadly of all brain cancers to treat. They found that none of the four different glioblastoma cell lines they tested expressed any detectable levels of AP-2(.

"The discovery of the ubiquitous loss of AP-2( in high-grade malignant gliomas provides a unique target for new therapies aimed at restoring the function of that gene," says Heimberger. "We are already looking at trying to replace AP-2( function in animal models with gene therapy in order to slow down growth of the tumor," McGary added.

Laura Sussman | EurekAlert!

More articles from Health and Medicine:

nachricht Researchers release the brakes on the immune system
18.10.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Norovirus evades immune system by hiding out in rare gut cells
12.10.2017 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Osaka university researchers make the slipperiest surfaces adhesive

18.10.2017 | Materials Sciences

Space radiation won't stop NASA's human exploration

18.10.2017 | Physics and Astronomy

Los Alamos researchers and supercomputers help interpret the latest LIGO findings

18.10.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>